Treatment
Nadunolimab clinical trials
We’re tracking 3 recruiting studies that include Nadunolimab, each written for real people, not researchers, below.
Recruiting studies
- NCT06548230RecruitingPhase 1/Phase 2
Nadunolimab plus azacitidine for MDS and AML
This trial tests a new combination of drugs (nadunolimab plus azacitidine, sometimes with venetoclax) for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that has not been treated much or has come back. The goal is to see if this combination can control the disease better.
Houston, TexasAges 18 years+ - NCT07284485RecruitingPhase 2
Preventing lung cancer in people with high-risk lung spots
This trial tests an immunotherapy approach to stop high-risk lung spots from turning into cancer. It is for people who are current or former heavy smokers with multiple slow-growing lung nodules that are not yet ready for surgery.
New York, New YorkAges 18 years+ - NCT07281716RecruitingPhase 1/Phase 2
Immunotherapy combo for advanced colorectal cancer
This trial tests a combination of immunotherapy drugs for people with a specific type of colorectal cancer (MSS, or microsatellite stable) that has stopped responding to standard chemotherapy. The goal is to see if this new treatment can shrink tumors or slow the cancer's growth.
New York, New YorkAges 18 years+
What Nadunolimab is being studied for
Conditions with recruiting Nadunolimab studies.
Common questions
- Are there clinical trials studying Nadunolimab?
- Yes. Clin2 currently lists 3 recruiting studies that include Nadunolimab, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Nadunolimab trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Nadunolimab an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Nadunolimab or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.